Research area
Health & Longevity
Human health, disease, treatment and aging. The largest corpus area supports distinct cancer, neurological and therapeutic navigation.
-
Evidence date ·Creatine users were satisfied and ready to continue, but many did not feel the benefits they wanted
Peer-Reviewed PaperIn a survey of 2,178 creatine users, 98% planned to continue, but only 35.6% of those seeking cognitive benefits felt they had gained them.
-
Evidence date ·A six-week test of online lessons and symptom tracking for dementia caregivers
Clinical TrialA registered Taiwan study tests six weeks of online lessons and symptom tracking with alternating assignment, comparing caregiver confidence, symptoms and burden.
-
Evidence date ·Why researchers may change creatine entry in opposite directions
Review or Meta-AnalysisA 2026 review explains limited supplementation benefit in transporter deficiency and preclinical tests of SLC6A8 inhibition in cancer.
-
Evidence date ·How gene regulation and daily rhythms may connect in an aging liver
Review or Meta-AnalysisA 2026 review connects gene regulation, circadian timing and liver aging, then asks what would be needed to turn experimental changes into human benefit.
-
Evidence date ·How engineered immune cells might clear senescent cells while preserving repair
Review or Meta-AnalysisA review explains how engineered T cells might clear senescent cells in mice, why persistence differs from drug dosing, and what complicates treatment in people.
-
Evidence date ·What an online caregiver group will test for Lewy body dementia
Clinical TrialA planned eight-week text group for Lewy body dementia caregivers will be compared with educational materials, with depression checked at week 8 and six months.
-
Evidence date ·What a six-month tocotrienol placebo trial will measure in adults aged 35–50
Clinical TrialA registered human trial compares six months of tocotrienol with placebo, measuring blood, mitochondrial and health signals; no results are posted in the snapshot.
-
Evidence date ·Why did regenerative cells work better after an immune treatment in mice?
Peer-Reviewed PaperA mouse study paired an immune treatment with regenerative cells, improving liver and survival measures after induced injury—not ordinary aging.
-
Evidence date ·How wakefulness signals may link disturbed sleep and Alzheimer’s changes
Review or Meta-AnalysisA June 4, 2026 review explains how orexin may link broken sleep with Alzheimer’s proteins, weighing receptor-blocking drugs and preclinical ginseng research.
-
Evidence date ·How a critical illness can affect brain function after the crisis
Review or Meta-AnalysisA June 2026 narrative review examines how inflammation may affect memory, why vulnerability varies, and what separates a target from a proven treatment.